Cargando…
Stilbene‐based derivatives as potential inhibitors of trimethylamine (TMA)‐lyase affect gut microbiota in coronary heart disease
Coronary heart disease (CHD) is defined by atherosclerosis, which may result in stenosis or blockage of the arterial cavity, leading to ischemic cardiac diseases such as angina and myocardial infarction (MI). Accumulating evidence indicates that the gut microbiota play a critical role in the initiat...
Autores principales: | Li, Jincai, Huang, Peng, Cheng, Wangxing, Niu, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834892/ https://www.ncbi.nlm.nih.gov/pubmed/36655110 http://dx.doi.org/10.1002/fsn3.3046 |
Ejemplares similares
-
The gene expression and bioinformatic analysis of choline trimethylamine-lyase (CutC) and its activating enzyme (CutD) for gut microbes and comparison with their TMA production levels
por: Ramireddy, Latha, et al.
Publicado: (2021) -
Simultaneous Measurement of Urinary Trimethylamine (TMA) and Trimethylamine N-Oxide (TMAO) by Liquid Chromatography–Mass Spectrometry
por: Jia, Xun, et al.
Publicado: (2020) -
Urinary TMAO Levels Are Associated with the Taxonomic Composition of the Gut Microbiota and with the Choline TMA-Lyase Gene (cutC) Harbored by Enterobacteriaceae
por: Dalla Via, Alessandro, et al.
Publicado: (2019) -
Electrophoretic Determination of Trimethylamine (TMA) in Biological Samples as a Novel Potential Biomarker of Cardiovascular Diseases Methodological Approach
por: Konop, Marek, et al.
Publicado: (2021) -
Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota
por: Hoyles, Lesley, et al.
Publicado: (2018)